Satoshi Morita
发表
Optimal Decision Criteria for the Study Design and Sample Size of a Biomarker-Driven Phase III Trial
Akira Takazawa,
Satoshi Morita,
S. Morita,
2020,
Therapeutic Innovation & Regulatory Science.